EHA25Virtual: Ruxolitinib, the First Proven Drug for Treating Steroid-refractory Acute GVHD
THE HAGUE, Netherlands, June 12, 2020 /PRNewswire/ — Acute graft-versus-host disease (GVHD) remains a major limitation of allogeneic stem-cell transplantation;